Clinical Trials Directory

Trials / Unknown

UnknownNCT05245045

Efficacy and Safety of STBF Photodynamic Therapy for Moderate and Severe Acne Vulgaris

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Shanghai Dermatology Hospital · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This study is being done to evaluate the efficacy and safety of Shengtaibufen photodynamic therapy (STBF-PDT) for treatment of moderate or severe acne vulgaris.

Detailed description

This study is a split randomized controlled trial and being done to evaluate the efficacy and safety of Shengtaibufen photodynamic therapy (STBF-PDT) for treatment of moderate or severe acne vulgaris.

Conditions

Interventions

TypeNameDescription
PROCEDUREShengtaibufen Photodynamic Therapy(STBF-PDT)Shengtaibufen Photodynamic Therapy(STBF-PDT)
PROCEDURERed lightRed light

Timeline

Start date
2022-02-10
Primary completion
2023-02-10
Completion
2023-02-10
First posted
2022-02-17
Last updated
2022-02-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05245045. Inclusion in this directory is not an endorsement.